---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-337962"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2026-08-06T20:05:37+00:00"
generated_at: "2026-08-06T20:07:45.846878+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed Q4 revenue up 9% to $1.5B; non-GAAP EPS $2.95 (+16%); dividend raised 10%

## Summary
- Q4 revenue $1.464B (+9% YoY); GAAP EPS $2.64 (+2%); non-GAAP EPS $2.95 (+16%).
- FY2026 revenue $5.653B (+10%); GAAP EPS $10.43; non-GAAP EPS $11.17 (+17%).
- FY2026 free cash flow $1.6B; returned $1.0B to shareholders; FY2027 capital return guided >$1.85B.
- Dividend increased 10% to $0.66/quarter; record date Aug 20, payable Sep 24.
- Agreement to sell MatrixCare (close Q1 FY2027); completed acquisition of Noctrix Health.

## SEC filing metadata
- accession: 0001193125-26-337962
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2026-08-06T20:05:37+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312526337962/0001193125-26-337962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312526337962/d158732d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-337962
- JSON: https://secwatch.observer/filing/0001193125-26-337962.json
- Plain text: https://secwatch.observer/filing/0001193125-26-337962.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.